Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26401
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCalifano, Alfonso Maria-
dc.contributor.authorBitker, Laurent-
dc.contributor.authorBaldwin, Ian C-
dc.contributor.authorFealy, Nigel G-
dc.contributor.authorBellomo, Rinaldo-
dc.date2020-02-21-
dc.date.accessioned2021-05-03T05:20:05Z-
dc.date.available2021-05-03T05:20:05Z-
dc.date.issued2020-02-21-
dc.identifier.citationBlood Purification 2020; 49(3): 281-288en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/26401-
dc.description.abstractContinuous renal replacement therapy (CRRT) technique may affect circuit lifespan. A shorter circuit life may reduce CRRT efficacy and increase costs. In a before-and-after study, we compared circuit median survival time during continuous venovenous hemofiltration (CVVH) versus continuous venovenous hemodialysis (-CVVHD). We performed log-rank mixed effects univariate analysis and Cox mixed effect regression modeling to define predictors of circuit lifespan. We compared 197 -CVVHD and 97 CVVH circuits in 39 patients. There was no overall difference in circuit lifespan. When no anticoagulation was used, median circuit survival time was shorter for CVVH circuits (5 h, 95% CI 3-7 vs. 10 h, 95% CI 8-13, p < 0.01). Moreover, CVVHD, lower platelets levels, and longer activated partial thromboplastin time independently predicted longer circuit median survival time. CVVHD is associated with longer circuit median survival time than CVVH when no anticoagulation is used and is an independent predictor of circuit survival.en
dc.language.isoeng
dc.subjectAcute kidney injuryen
dc.subjectAnticoagulationen
dc.subjectCircuit survivalen
dc.subjectClottingen
dc.subjectContinuous renal replacement therapyen
dc.subjectContinuous venovenous hemodialysisen
dc.titleCircuit Survival during Continuous Venovenous Hemodialysis versus Continuous Venovenous Hemofiltration.en
dc.typeJournal Articleen
dc.identifier.journaltitleBlood Purificationen
dc.identifier.affiliationDepartment of Nephrology, Hospital del Mar, Barcelona, Spainen
dc.identifier.affiliationIntensive Careen
dc.identifier.affiliationService de Médecine Intensive et Réanimation, Hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, Franceen
dc.identifier.affiliationCentre for Integrated Critical Care, The University of Melbourne, Melbourne, Victoria, Australiaen
dc.identifier.doi10.1159/000504037en
dc.type.contentTexten
dc.identifier.pubmedid32088713
local.name.researcherBaldwin, Ian C
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

56
checked on Jul 24, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.